AstraZeneca, Others Must Expand Diabetes Drug Warnings
The U.S. Food and Drug Administration on Friday ordered AstraZeneca PLC, Johnson & Johnson unit Janssen Pharmaceuticals Inc., and other makers of diabetes drugs to update their labels with the risk...To view the full article, register now.
Already a subscriber? Click here to view full article